The influence of mixed HCMV UL97 wildtype and mutant strains on ganciclovir susceptibility in a cell associated plaque reduction assay

Journal of Clinical Virology

Volumn 30, Issue 1, 2004, Pages 50-56

  Eckle, Tobias ^a   Jahn, Gerhard ^a   Hamprecht, Klaus ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Cytomegalovirus; GCV resistance; Phenotypical drug resistance; Stem cell transplantation

Indexed keywords

GANCICLOVIR;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; CODON; CONTROLLED STUDY; DRUG SENSITIVITY; FOLLOW UP; GENOTYPE; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; NONHUMAN; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PRIORITY JOURNAL; RELIABILITY; SCHOOL CHILD; SCREENING; VIRUS CULTURE; VIRUS MUTANT; VIRUS MUTATION; VIRUS RESISTANCE; VIRUS STRAIN; WILD TYPE;

ADOLESCENT; ADULT; ANTIVIRAL AGENTS; CHILD; CODON; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DNA FINGERPRINTING; DNA, VIRAL; DRUG RESISTANCE, VIRAL; GANCICLOVIR; HUMANS; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MUTATION, MISSENSE; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PHENOTYPE; PLAQUE ASSAY; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; SEQUENCE ANALYSIS, DNA;

EID: 1842504417     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2003.08.010     Document Type: Article

References (27)

1. Boivin G., Gilbert C., Morissette M., Handfield J., Goyette N., Bergeron M.G. A case of ganciclovir-resistant cytomegalovirus (CMV) retinitis in a patient with AIDS: longitudinal molecular analysis of the CMV viral load and viral mutations in blood compartments. Aids. 11(7):1997;867-873.
2. Bowen E.F., Emery V.C., Wilson P., Johnson M.A., Davey C.C., Sabin C.A., Farmer D., Griffiths P.D. Cytomegalovirus polymerase chain reaction viraemia in patients receiving ganciclovir maintenance therapy for retinitis. Aids. 12(6):1998;605-611.
3. Chou S., Marousek G., Guentzel S., Follansbee S.E., Poscher M.E., Lalezari J.P., Miner R.C., Drew W.L. Evolution of mutations conferring multidrug resistance during prophylaxis and therapy for cytomegalovirus disease. J. Infect. Dis. 176(3):1997;786-789.
4. Chou S., Waldemer R.H., Senters A.E., Michels K.S., Kemble G.W., Miner R.C., Drew W.L. Cytomegalovirus UL97 phosphotransferase mutations that affect susceptibility to ganciclovir. J. Infect. Dis. 185(2):2002;162-169.
5. Drew W.L., Paya C.V., Emery V. Cytomegalovirus (CMV) resistance to antivirals. Am. J. Transplant. 1(4):2001;307-312.
6. Eckle T., Prix L., Jahn G., Klingebiel T., Handgretinger R., Selle B., Hamprecht K. Drug-resistant human cytomegalovirus infection in children after allogeneic stem cell transplantation may have different clinical outcomes. Blood. 96(9):2000;3286-3289.
7. Eckle T., Lang P., Prix L., Jahn G., Klingebiel T., Handgretinger R., Selle B., Niethammer D., Hamprecht K. Rapid development of ganciclovir- resistant cytomegalovirus infection in children after allogeneic stem cell transplantation in the early phase of immune cell recovery. Bone Marrow Transplant. 30(7):2002;433-439.
8. Eckle T., Jahn G., Hamprecht K. High impact of an expanded restriction fragment length polymorphism assay on detection of ganciclovir-resistant UL97 mutants of human cytomegalovirus. Antimicrob. Agents Chemother. 47(1):2003;442-443.
9. Emery V.C. Progress in understanding cytomegalovirus drug resistance. J. Clin. Virol. 21(3):2001;223-228.
10. Erice A. Resistance of human cytomegalovirus to antiviral drugs. Clin. Microbiol. Rev. 12(2):1999;286-297.
11. Erice A., Borrell N., Li W., Miller W.J., Balfour H.H. Jr. Ganciclovir susceptibilities and analysis of UL97 region in cytomegalovirus (CMV) isolates from bone marrow recipients with CMV disease after antiviral prophylaxis. J. Infect. Dis. 178(2):1998;531-534.
12. Gilbert C., Handfield J., Toma E., Lalonde R., Bergeron M.G., Boivin G. Emergence and prevalence of cytomegalovirus UL97 mutations associated with ganciclovir resistance in AIDS patients. Aids. 12(2):1998;125-129.
13. Gilbert C., Roy J., Belanger R., Delage R., Beliveau C., Demers C., Boivin G. Lack of emergence of cytomegalovirus UL97 mutations conferring ganciclovir (GCV) resistance following preemptive GCV therapy in allogeneic stem cell transplant recipients. Antimicrob. Agents Chemother. 45(12):2001;3669-3671.
14. Hamprecht K., Eckle T., Prix L., Faul C., Einsele H., Jahn G. Ganciclovir-resistant cytomegalovirus disease after allogeneic stem cell transplantation: pitfalls of phenotypic diagnosis by in vitro selection of an UL97 mutant strain. J. Infect. Dis. 187(1):2003;139-143.
15. Jabs D.A., Martin B.K., Forman M.S., Dunn J.P., Davis J.L., Weinberg D.V., Biron K.K., Baldanti F. Mutations conferring ganciclovir resistance in a cohort of patients with acquired immunodeficiency syndrome and cytomegalovirus retinitis. J. Infect. Dis. 183(2):2001;333-337.
16. Landry M.L., Stanat S., Biron K., Brambilla D., Britt W., Jokela J., Chou S., Drew W.L., Erice A., Gilliam B., Lurain N., Manischewitz J., Miner R., Nokta M., Reichelderfer P., Spector S., Weinberg A., Yen-Lieberman B., Crumpacker C. A standardized plaque reduction assay for determination of drug susceptibilities of cytomegalovirus clinical isolates. Antimicrob. Agents Chemother. 44(3):2000;688-692.
17. Limaye A.P. Ganciclovir-resistant cytomegalovirus in organ transplant recipients. Clin. Infect. Dis. 35(7):2002;866-872.
18. Limaye A.P., Raghu G., Koelle D.M., Ferrenberg J., Huang M.L., Boeckh M. High incidence of ganciclovir-resistant cytomegalovirus infection among lung transplant recipients receiving preemptive therapy. J. Infect. Dis. 185(1):2002;20-27.
19. Liu W., Kuppermann B.D., Martin D.F., Wolitz R.A., Margolis T.P. Mutations in the cytomegalovirus UL97 gene associated with ganciclovir- resistant retinitis. J. Infect. Dis. 177(5):1998;1176-1181.
20. Lurain N.S., Weinberg A., Crumpacker C.S., Chou S. Sequencing of cytomegalovirus UL97 gene for genotypic antiviral resistance testing. Antimicrob. Agents Chemother. 45(10):2001;2775-2780.
21. Lurain N.S., Bhorade S.M., Pursell K.J., Avery R.K., Yeldandi V.V., Isada C.M., Robert E.S., Kohn D.J., Arens M.Q., Garrity E.R., Taege A.J., Mullen M.G., Todd K.M., Bremer J.W., Yen-Lieberman B. Analysis and characterization of antiviral drug-resistant cytomegalovirus isolates from solid organ transplant recipients. J. Infect. Dis. 186(6):2002;760-768.
22. Pepin J.M., Simon F., Dussault A., Collin G., Dazza M.C., Brun-Vezinet F. Rapid determination of human cytomegalovirus susceptibility to ganciclovir directly from clinical specimen primocultures. J. Clin. Microbiol. 30(11):1992;2917-2920.
23. Prix L., Maierl J., Jahn G., Hamprecht K. A simplified assay for screening of drug resistance of cell-associated cytomegalovirus strains. J. Clin. Virol. 11(1):1998;29-37.
24. Prix L., Hamprecht K., Holzhuter B., Handgretinger R., Klingebiel T., Jahn G. Comprehensive restriction analysis of the UL97 region allows early detection of ganciclovir-resistant human cytomegalovirus in an immunocompromised child. J. Infect. Dis. 180(2):1999;491-495.
25. Smith I.L., Cherrington J.M., Jiles R.E., Fuller M.D., Freeman W.R., Spector S.A. High-level resistance of cytomegalovirus to ganciclovir is associated with alterations in both the UL97 and DNA polymerase genes. J. Infect. Dis. 176(1):1997;69-77.
26. Wolf D.G., Yaniv I., Honigman A., Kassis I., Schonfeld T., Ashkenazi S. Early emergence of ganciclovir-resistant human cytomegalovirus strains in children with primary combined immunodeficiency. J. Infect. Dis. 178(2):1998;535-538.
27. Wolf D.G., Lurain N.S., Zuckerman T., Hoffman R., Satinger J., Honigman A., Saleh N., Robert E.S., Rowe J.M., Kra-Oz Z. Emergence of late cytomegalovirus central nervous system disease in hematopoietic stem cell transplant recipients. Blood. 22:2002;22.